How to buy Liminal BioSciences stock (LMNL)

Liminal BioSciences is a biotechnology business based in the US. Liminal BioSciences shares (LMNL) are listed on the NASDAQ and all prices are listed in US Dollars.

Our top picks for where to buy Liminal BioSciences stock

Buy Liminal BioSciences stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Liminal BioSciences stock price (NASDAQ: LMNL)

Use our graph to track the performance of LMNL stocks over time.

Liminal BioSciences shares at a glance

• Key figures

Information last updated 2023-11-19.

52-week range	$0.00 - $0.00
50-day moving average more info button	$8.41
200-day moving average more info button	$6.29
Wall St. target price	$10.16
PE ratio more info button	N/A
Dividend yield more info button	$0 (0%)
Earnings per share (TTM) more info button	$-6.83

Is it a good time to buy Liminal BioSciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Liminal BioSciences financials

Revenue TTM	$492,000
Gross profit TTM	$-14,897,000
Return on assets TTM	-38.95%
Return on equity TTM	-141.94%
Profit margin	267.48%
Book value	$6.61
Market Capitalization more info button	$27.6 million

TTM: trailing 12 months

Liminal BioSciences share dividends

We're not expecting Liminal BioSciences to pay a dividend over the next 12 months.

Have Liminal BioSciences's shares ever split?

Liminal BioSciences's shares were split on a 1:10 basis on 31 January 2023 . So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Liminal BioSciences shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Liminal BioSciences shares which in turn could have impacted Liminal BioSciences's share price.

Liminal BioSciences share price volatility

Over the last 12 months, Liminal BioSciences's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Liminal BioSciences's is 29.3405. This would suggest that Liminal BioSciences's shares are significantly more volatile than the average for this exchange and represent a higher risk.

Liminal BioSciences overview

Liminal BioSciences Inc. , a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company is developing LMNL6511, a selective antagonist for the G-protein coupled receptor 84, is expected to commence a Phase 1 clinical trial. It is also developing potential OXER1 antagonists and GPR40 agonists, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019.

Frequently asked questions

What percentage of Liminal BioSciences is owned by insiders or institutions?
Currently 61.26% of Liminal BioSciences shares are held by insiders and 0.77% by institutions. When does the fiscal year end for Liminal BioSciences?
Liminal BioSciences's fiscal year ends in December. Where is Liminal BioSciences based?
Liminal BioSciences's address is: 440 Armand-Frappier Boulevard, Laval, QC, Canada, H7V 4B4 What is Liminal BioSciences's ISIN number?
Liminal BioSciences's international securities identification number is: CA53272L1031 What is Liminal BioSciences's CUSIP number?
Liminal BioSciences's Committee on Uniform Securities Identification Procedures number is: 53272L103